SynthesisFrontiers in oncology2026

Efficacy and toxicities of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel as first-line chemotherapy for unresectable pancreatic cancer: a systematic review and meta-analysis.

Chunle Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.